Cargando…
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
BACKGROUND: Autoimmunity is a common cause of pulmonary fibrosis and can present either as a manifestation of an established connective tissue disease or as the recently described entity of interstitial pneumonia with autoimmune features. The rate of progression and responsiveness to immunosuppressi...
Autores principales: | Odackal, John, Yu, Victor, Gomez-Manjerres, Diana, Field, Joshua J., Burdick, Marie D., Mehrad, Borna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682700/ https://www.ncbi.nlm.nih.gov/pubmed/33263049 http://dx.doi.org/10.1183/23120541.00481-2020 |
Ejemplares similares
-
Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial
por: Gomez-Manjarres, Diana C., et al.
Publicado: (2023) -
Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study
por: Lin, Christine M., et al.
Publicado: (2020) -
The Role of Fibrocytes in Sickle Cell Lung Disease
por: Field, Joshua J., et al.
Publicado: (2012) -
Fibrocytes and the pathogenesis of diffuse parenchymal lung disease
por: Mehrad, Borna, et al.
Publicado: (2012) -
The role of fibrocytes in fibrotic diseases of the lungs and heart
por: Keeley, Ellen C, et al.
Publicado: (2011)